JPS56150091A - 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture - Google Patents

3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture

Info

Publication number
JPS56150091A
JPS56150091A JP4260581A JP4260581A JPS56150091A JP S56150091 A JPS56150091 A JP S56150091A JP 4260581 A JP4260581 A JP 4260581A JP 4260581 A JP4260581 A JP 4260581A JP S56150091 A JPS56150091 A JP S56150091A
Authority
JP
Japan
Prior art keywords
piperidinylalkyl
pyrido
pyrimidine
derivative
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4260581A
Other languages
Japanese (ja)
Other versions
JPH0215550B2 (en
Inventor
Ii Jiee Kenisu Rudo
Shii Merutensu Jiyosefusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of JPS56150091A publication Critical patent/JPS56150091A/en
Publication of JPH0215550B2 publication Critical patent/JPH0215550B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
JP4260581A 1980-03-28 1981-03-25 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture Granted JPS56150091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
JPS56150091A true JPS56150091A (en) 1981-11-20
JPH0215550B2 JPH0215550B2 (en) 1990-04-12

Family

ID=22465278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4260581A Granted JPS56150091A (en) 1980-03-28 1981-03-25 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture

Country Status (5)

Country Link
JP (1) JPS56150091A (en)
KR (2) KR850000412B1 (en)
PL (2) PL132428B1 (en)
SU (1) SU1093251A3 (en)
ZA (1) ZA812085B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227565A (en) * 1985-04-01 1986-10-09 Eisai Co Ltd Novel piperidine derivative
JPH029808A (en) * 1988-03-28 1990-01-12 Janssen Pharmaceut Nv Drug for maintaining and recovering health of a skin
JP2015508075A (en) * 2012-02-10 2015-03-16 ピーティーシー セラピューティクス， インコーポレイテッド Compounds for treating spinal muscular atrophy
JP2015143255A (en) * 2008-02-29 2015-08-06 ブイエム ディスカバリー インコーポレイテッド Method for treating pain syndrome and other disorders
US10874672B2 (en) 2015-12-10 2020-12-29 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11602567B2 (en) 2015-05-30 2023-03-14 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US11608501B2 (en) 2017-06-14 2023-03-21 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
US11702646B2 (en) 2016-11-28 2023-07-18 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US11780839B2 (en) 2018-03-27 2023-10-10 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11858941B2 (en) 2018-06-27 2024-01-02 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (en) * 1985-04-01 1994-03-02 エーザイ株式会社 Novel piperidine derivative
JPS61227565A (en) * 1985-04-01 1986-10-09 Eisai Co Ltd Novel piperidine derivative
JPH029808A (en) * 1988-03-28 1990-01-12 Janssen Pharmaceut Nv Drug for maintaining and recovering health of a skin
US9834555B2 (en) 2008-02-29 2017-12-05 VM Therapeutics LLC. Method for treating pain syndrome and other disorders
JP2015143255A (en) * 2008-02-29 2015-08-06 ブイエム ディスカバリー インコーポレイテッド Method for treating pain syndrome and other disorders
US9402848B2 (en) 2008-02-29 2016-08-02 Vm Therapeutics Llc Method for treating pain syndrome and other disorders
US10851101B2 (en) 2012-02-10 2020-12-01 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9586955B2 (en) 2012-02-10 2017-03-07 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9879007B2 (en) 2012-02-10 2018-01-30 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
JP2015508075A (en) * 2012-02-10 2015-03-16 ピーティーシー セラピューティクス， インコーポレイテッド Compounds for treating spinal muscular atrophy
US11753407B2 (en) 2012-02-10 2023-09-12 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
JP2017122097A (en) * 2012-02-10 2017-07-13 ピーティーシー セラピューティクス， インコーポレイテッド Compounds for treating spinal muscular atrophy
US11602567B2 (en) 2015-05-30 2023-03-14 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US10874672B2 (en) 2015-12-10 2020-12-29 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US10881658B2 (en) 2015-12-10 2021-01-05 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11702646B2 (en) 2016-11-28 2023-07-18 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11608501B2 (en) 2017-06-14 2023-03-21 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
US11780839B2 (en) 2018-03-27 2023-10-10 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
US11858941B2 (en) 2018-06-27 2024-01-02 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease

Also Published As

Publication number Publication date
PL230364A1 (en) 1982-03-29
SU1093251A3 (en) 1984-05-15
ZA812085B (en) 1982-11-24
KR850000413B1 (en) 1985-03-26
KR850000412B1 (en) 1985-03-26
PL233902A1 (en) 1982-07-19
KR830005220A (en) 1983-08-03
JPH0215550B2 (en) 1990-04-12
PL131162B1 (en) 1984-10-31
PL132428B1 (en) 1985-03-30

Similar Documents

Publication Publication Date Title
PT72740A (en) Novel 3-(1-piperidinylalkyl)-4h-pyrido/1,2-a/-pyrimidin-4-one derivatives
AU540840B2 (en) Imidazo(1,2-a)pyridines
AU556062B2 (en) Imidazo (1,2-a) pyridines and pyrazines
PH17158A (en) Imidazo(1,2-a)pyridin-2-yl carbostyril derivatives and compositions containing same
ZA832788B (en) Imidazo(1,2-a)pyridine derivatives
JPS56150091A (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture
AU7600481A (en) Imidazo (4,5-b)pyridines
AU8752482A (en) Imidazo (1,2-a)quinazolin-2-ones
PH23147A (en) Imidazo/1,5-a/pyridine derivatives
GB2050353B (en) Substituted pyrido(1,2-a) pyrimidines
AU573880B2 (en) Imidazo (1.2-a) quinolines
GB2087390B (en) 5,6,7,8-tetrahydro-1,6-naphthyridine derivatives and their preparation
AU5771780A (en) 3-substituted imidazo (1,2-a) pyridines
AU546194B2 (en) Pyrido (1,2-a)pyrimidines and their preparation
AU551160B2 (en) Benzazepino-(4,3,2-ij)pyrazino(1,2-a)quinoline derivatives
GB2080794B (en) 1,6-naphthyridine derivatives
PH20432A (en) Novel imidazo 1,2-a pyridines
AU550521B2 (en) Pyrido (1,2-a)pyrimidines and preparation thereof
JPS5732283A (en) Indolo(2',3';3,4)pyrido(2,1-b)quinazoline-5-one and manufacture
AU552028B2 (en) Imidazo(1,5-a)pyridines and imidazo(5,1-c) (1,4) thiazines
AU4624379A (en) Pyrido(1,2-a)pyrimidines
ZA815026B (en) 2,3,6,7-tetrahydrothiazolo(3,2-a)-pyrimidine derivatives
ATE11415T1 (en) 3-(1-PIPERIDINYLALKYL)-4H-PYRIDO(1,2-A)PYRIMIDI - 4-ONE DERIVATIVES.
PH15978A (en) 1,2-dihydro-5-pyridinyl-3h-pyrazolo(3,4-b) pyridin-3-one and their use as cardiotonics
IE871288L (en) PYRAZOLO (3,4-b) PYRIDINE DERIVATIVES